Histopathological analysis of xenograft tumors revealed that LPE18:1 treatment alone significantly promoted tumor growth, whereas simultaneous CAPZA1 knockdown obviously attenuated LPE18:1-induced tumor progression (Fig. 5b). The gene discussed is CAPZA1; the disease is neoplasm.